Clinical Trial

Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 16, 2025 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study tests the efficacy of a dyadic intervention to mitigate the adverse health consequences of severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2 )(COVID-19) in African American (AA) adults with pre-existing chronic health conditions and their informal carepartners (IC). Socioeconomically disadvantaged, older, and Black/African American from rural regions are burdened with greater rates of chronic diseases such as diabetes, hypertension, chronic kidney disease, cardiovascular disease, and stroke.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2022-05-09; most recent amendment 2025-05-13.
Status change: Not Yet Recruiting → Recruiting 2023-05-18
Trial Details
NCT Number NCT05370014
Lead Sponsor University of South Carolina
Collaborators: National Institute of Nursing Research (NINR)
Conditions SARS- CoV-2, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus, Type 2, Chronic Disease, Stroke
Enrollment 500 participants
Start Date 2023-01-03
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-16